Ensysce Biosciences Inc Strategic Asset Allocation Index
Ensysce Biosciences Inc strategic asset allocation index. Ensysce Biosciences Inc (ENSC) has a Strategic Asset Allocation Index of 4.3% as of December 2025. Strategic assets (PP&E of $124.13K plus long-term investments of $-) total $124.13K, measured against net assets of $2.88 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Ensysce Biosciences Inc to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Ensysce Biosciences Inc (2019–2019)
Strategic asset allocation index of Ensysce Biosciences Inc from 2019 to 2019. This chart shows how Ensysce Biosciences Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2019 to 2019. As of December 2025, the index stands at 4.3%, representing strategic assets of $124.13K against net assets of $2.88 Million USD.
Ensysce Biosciences Inc Strategic Asset Allocation Index by Year (2019–2019)
Ensysce Biosciences Inc strategic asset allocation index by year from 2019 to 2019. The table below presents the year-by-year Strategic Asset Allocation Index for Ensysce Biosciences Inc from 2019 to 2019, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Ensysce Biosciences Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 0.0% | $351.00 | $351.00 | $- | $186.17 Million | — |